Skip to main content
Home

Breadcrumb

  1. Home
  2. Artificial Intelligence

Artificial Intelligence

1 August 2023

Lighthouse Advisory Partners acts as lead advisor for Causeway on its acquisition of one.network from Bridgepoint

Lighthouse Advisory Partners continues a strong 2023 with another landmark M&A deal in the construction technology sector. ...

2 June 2021

How Can We Tackle Emergency Department Crowding Once And For All? (Part 3 Of 3)

This article is the third in a three-part series which seeks to dissect the challenge of emergency department (ED) crowding; why it occurs, why it’s a problem and what we need to do to overcome it. The creation of this series is driven by the ever-pressing need to secure the sustainabil...

26 May 2021

How Does Emergency Department Crowding Impact Care? (Part 2 Of 3)

This article is the second in a three-part series which seeks to dissect the challenge of emergency department (ED) crowding; why it occurs, why it’s a problem and what we need to do to overcome it. The creation of this series is driven by the ever-pressing need to secure the sustainabi...

19 May 2021

What Causes Emergency Department Crowding? (Part 1 Of 3)

This article is the first in a three-part series which seeks to dissect the challenge of emergency department (ED) crowding; why it occurs, why it’s a problem and what we need to do to overcome it. The creation of this series is driven by the ever-pressing need to secure the sustainabil...

23 February 2023

COPD Management Empowerment

Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung condition characterised by difficulty breathing, coughing and other respiratory symptoms. It is a progressive disease, meaning that these symptoms typically get worse over time. COPD is the sixth leading cause of death in th...

20 March 2023

Spirometry and COPD

Spirometry is a commonly used diagnostic test that measures the amount of air a person can inhale and exhale and the speed at which they can do so [1]. It is often used to diagnose and monitor conditions such as asthma and chronic obstructive pulmonary disease (COPD) [1]. While spiromet...

26 March 2021

A New Therapeutic Paradigm For Epilepsy

Epilepsy is a chronic neurological disease which affects around 50 million people of all ages worldwide [1]. The disease is characterised by recurrent seizures caused as a result of excessive electrical discharges in a group of brain cells. Epilepsy is non-contagious, and although there...

5 February 2021

The Global Blood Pressure Problem: is the Solution Staring Us in the Face?

LET'S START WITH THE FACTS

5 February 2021

The Global Blood Pressure Problem: is the Solution Staring Us In The Face?

LET'S START WITH THE FACTS

28 July 2023

electronRx moves to new premises to facilitate growth plans

Cambridge-based health tech company electronRx has moved into its new office within Compass House in Histon to facilitate its future expansion. ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 55
  • Page 56
  • Current page 57
  • Page 58
  • Page 59
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS